Contribution
We are very committed, as I hope the hon. Lady knows, to the workforce plan being as robust as it can be, so we do not just get the pharmacists of the future but the doctors, nurses, healthcare workers and so on too. On the journey to a national health service that is much more community focused and much more aligned to prevention rather than to curing sickness—we want to prevent people from becoming ill in the first place—we must ensure that at its heart is how we can deliver medicines and treatments closer to where people live. Having well-trained capabilities in the pharmacy sector to do that is very much a priority for this Government.
Returning to the issue of the two Boots closures in Hampton, the Minister for Care is aware of the closures. He asked me to communicate to the hon. Lady the fact that he will keep a very close eye on what is happening on the ground in her area.
On the hon. Lady’s specific point about bureaucracy, I assure her that the regulatory framework is always under review, and as a new Government we are keen to make improvements wherever we can. I am sure that my officials will have heard the case that she has made.
After the hon. Lady kindly reached out to me prior to the debate, I instructed officials to ask her ICB to consider her concerns again. I hear that she has had a reply that was not particularly helpful. Again, I hope that her ICB is watching this debate, and listening to her case and to me as the Minister saying from the Dispatch Box that we take these issues seriously. Good access to pharmacy services is important to her constituents and to the constituents of Members right across the House. We need to make sure that the network is protected and enhanced.
On funding, NHS England has commissioned an economic analysis of the cost of providing pharmaceutical services. That work is happening right now with the pharmacy sector and we look forward to seeing the outcome. Previous Governments dithered and delayed on finding a sustainable and long-term solution. The consultation around this year’s funding and contractual arrangements with Community Pharmacy England did not make it over the line before the election was called, so we as Ministers are looking at that as a matter of urgency.
All that we are speaking of today is against the backdrop of the most challenging circumstances since the second world war. That is why the Chancellor is carrying out an urgent assessment of our spending inheritance and will be presenting the results to Parliament before the summer recess, so that the findings can inform every spending decision we make.
In the meantime, I am afraid that I cannot update the House on this year’s arrangements. I understand that that will be frustrating to the hon. Lady, but the Prime Minister has asked me and every Minister of this Government to be honest and open about the state of the nation’s finances. I intend to keep that promise, but I look forward to working with pharmacy stakeholders to discuss not just how we solve these problems, but how we seize the opportunities for transformation in the sector, and how we deliver health and social care in the community, closer to where people need it, providing the new, innovative treatments from pharmacies where that is appropriate. This Government will always put patients before politics.
In the spirit of the friendship that we have developed over the years, particularly over the kinship issue, I look forward to working with the hon. Lady on this and other health-related issues, and on making our country a better, fairer and more equal place for her constituents and mine, with better access to health services, including community pharmacy. I hope to work with her in the years to come, and let us hope that we can improve the pharmacy services for Hampton and other parts of England.
Question put and agreed to.